Irbesartan Tablet
Product Images NDC 29300-213

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 29300-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 01

Chemical structure of irbesartan, depicting its molecular framework including ring systems and side chains, consistent with the active ingredient in the oral tablet form by Unichem Pharmaceuticals.*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 02

A dose-response curve illustrating the relationship between irbesartan dose (mg/day) on the x-axis and the placebo-subtracted reduction in trough systolic blood pressure (SeSBP) in mmHg on the y-axis. Data points are plotted with a fitted curve showing pressure reduction increases with dose up to a plateau.*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 03

A line graph depicting the placebo-subtracted reduction in trough SeDBP (mmHg) as a function of Irbesartan dose (mg/day), showing an integrated analysis of dose-response. The dose ranges from 0 to about 900 mg/day on the x-axis, and the SeDBP reduction ranges from approximately -2 to 8 mmHg on the y-axis.*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 04

A cumulative event rate line graph comparing three treatments: Irbesartan, Amlodipine, and Placebo over 60 months of follow-up. The graph shows event rates increasing over time, with Irbesartan generally indicating a lower cumulative event rate than Placebo and Amlodipine. A small inset displays relative risk (RR) values and p-values for comparisons between treatments.*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 05

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 06

Irbesartan Tablets USP 75 mg oral tablet label from Unichem Pharmaceuticals (USA), Inc. The label includes the National Drug Code (NDC) 29300-212-13, packaging quantity of 30 tablets, and storage instructions to keep at controlled room temperature. It also shows the manufacturer as UNICHEM LABORATORIES LTD. and emphasizes prescription use only.*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 07

Label of Irbesartan Tablets USP 150 mg oral tablets, with NDC 29300-213-13, manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. The label states a package size of 30 tablets and includes storage instructions to keep between 20° to 25°C (68° to 77°F).*

FDA Label Image

E26e3540 0045 4ca7 8398 6e27f1aaf3f8 08

Label for Irbesartan Tablets USP 300 mg oral tablets by Unichem Pharmaceuticals (USA), Inc. The label states the tablet strength as 300 mg, with a quantity of 30 tablets. It includes storage instructions, a barcode, and manufacturer information for Unichem Laboratories Ltd., India, and Unichem Pharmaceuticals (USA), Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.